RxDoctor Payments Data

Jazmyn Childress

Psychiatric/Mental Health · Torrance, CANPI 1679281380

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 220 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,315, 2.8 times the $1,185 reported in 2023. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,060in general payments, 2019–2025

Across 220 payments — averaging $32.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Vanda Pharmaceuticals Inc.$731
  • Otsuka America Pharmaceutical, Inc.$677
  • Lundbeck LLC$628
  • Teva Pharmaceuticals USA, Inc.$621
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$615
  • plus $2K from 12 others

What the payments were for

  • Food & beverage$6,93798%
  • Education$1232%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,060 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin33$983
Quetiapine Fumarate23$430
Mirtazapine22$209
Lorazepam17$106

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Torrance

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →